Screener
United Therapeutics UTHR Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
FAQ
- What is United Therapeutics's price / sales?
- United Therapeutics (UTHR) reported price / sales of 8.2× in Q1 2026.
- How has United Therapeutics's price / sales changed year-over-year?
- United Therapeutics's price / sales increased by 77.3% year-over-year, from 4.6× to 8.2×.
- What is the long-term trend for United Therapeutics's price / sales?
- Over 5 years (2020 to 2025), United Therapeutics's price / sales has grown at a 7.4% compound annual growth rate (CAGR), from 4.6× to 6.6×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about United Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude